Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market Access

Set Alert for Market Access

Medtronic Introduces Hugo To Rival Intuitive's Robotic Surgery System

The company unveiled its new modular robotic surgery system for minimally invasive surgery at a special event in Hartford, CT. Medtronic expects the new system to earn a CE mark by early 2021 and FDA approval by the end of 2021.

Innovation Launches Research & Development
Advertisement

Latest From Market Access

UK IVDs Broach Brexit Preparedness In Case Of No-Deal EU Exit

With the current Brexit date less than a month away, the UK IVDs industry is busy providing support to UK manufacturers and the pathology sector in an attempt to ensure no one gets caught out. Coinciding with this are the ongoing preparations for the EU IVDR, and a raft of UK-specific issues for the diagnostics industry.          

United Kingdom Medical Device

Australia Reviews Ban On Many Self-Testing IVDs

A new public consultation is looking at whether Australia’s rules prohibiting the supply of many types of self-testing IVDs are still fit for purpose.

In Vitro Diagnostics Australia

Market Brief: Global Fracture Fixation Market To Hit $10.8Bn By 2023

The global market for fracture fixation products is expected to reach nearly $10.8bn by 2023, a CAGR of 5.9%. Internal fixation devices for small-bone fractures are expected to see the largest growth over the forecast period, according to a new analysis by Meddevicetracker.

Orthopedics Surgery

QUOTED. 29 August 2019. Tim Herbert.

Medicare administrative contractors for 19 US states have proposed supplying local Medicare coverage for hypoglossal nerve stimulation (HNS) provided by Inspire Medical Systems’ Inspire therapy to treat obstructive sleep apnea. See what company president and CEO Tim Herbert said about it here.

Quoted Medicare

CMS Contractors Propose LCD Payments For Inspire Medical’s Sleep Apnea Nerve Stimulation Device

Noridian and Palmetto – two Medicare administrative contractors (MACs) serving 19 states in the West and Southeast – on 26 August proposed local coverage determinations (LCDs) for Inspire Medical Systems Inc.’s hypoglossal nerve stimulation devices to treat obstructive sleep apnea.

Medicare Market Access

UK NHS Rolls Out Roche Diagnostics Pre-Eclampsia Test

UK NHS is now using a blood test developed by Roche Diagnostics for predicting pre-eclampsia in pregnant women.

Market Access Diagnostics
See All
UsernamePublicRestriction

Register

Advertisement